Silphium Asset Management LTD Standard Biotools Inc. Transaction History

Silphium Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2025	SELL	$7.18 - $8.83 $206,877 - $254,418	-28,813 Closed	0 $0
Q3 2018 Jan 30, 2025	BUY	$5.92 - $8.35 $170,572 - $240,588	28,813 New	28,813 $216 Million
Q2 2018 Jan 30, 2025	SELL	$4.86 - $6.24 $77,021 - $98,891	-15,848 Closed	0 $0
Q1 2018 Jan 30, 2025	BUY	$5.75 - $7.97 $91,126 - $126,308	15,848 New	15,848 $92.6 Million

143

276M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $127M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Silphium Asset Management LTD with notifications on news.